Bismuth subgallate
As of the edition of 20 October 2026, Bismuth subgallate is a small molecule: marketed; acts on F12.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Small molecule
- Brand name
- Anusol
- Approvals on record
- 7 in 7 regions
- Holder of the most recent approval
- Laboratório Medinfar - Produtos Farmacêuticos, S.A.; 6 holders in all
- Withdrawn from market
- 1 January 1975 (in some regions)
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| F12 | Coagulation factor XII | P00748 |